Núria Pujol-Moix

Núria Pujol-Moix

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2015 in Platelets
Verified
Journal Article
Open access
Luigi Maria LaroccaLuigi Maria Larocca
Luigi Maria Larocca
PHPaula G. Heller
Paula G. Heller
GPGian Marco Podda
Gian Marco Podda
NPNúria Pujol-Moix
Núria Pujol-Moix
AGAna C. Glembotsky
Ana C. Glembotsky
ECErica De Candia
Erica De Candia
The gray platelet syndrome (GPS) is a rare congenital platelet disorder characterized by mild to moderate bleeding diathesis, macrothrombocytopenia and lack of azurophilic α-granules in platelets. Some platelet and megakaryocyte (MK) abnormalities have been described, but confirmative studies of the defects in larger patient cohorts have not been undertaken. We studied platelet function and bone marrow (BM) features in five GPS patients with NBEAL2 autosomal recessive mutations from four unrelated families. In 3/3 patients, we observed a defect in platelet responses to protease-activated receptor (PAR)1-activating peptide as the most consistent finding, either isolated or combined to defective responses to other agonists. A reduction of PAR1 receptors with normal expression of major glycoproteins on the platelet surface was also found. Thrombin-induced fibrinogen binding to platelets was severely impaired in 2/2 patients. In 4/4 patients, the BM biopsy showed fibrosis (grade 2-3) and extensive emperipolesis, with many (36-65%) MKs containing 2-4 leukocytes engulfed within the cytoplasm. Reduced immunolabeling for platelet factor 4 together with normal immunolabeling for CD63 in MKs of two patients demonstrated that GPS MKs display an alpha granule-specific defect. Increased immunolabeling for P-selectin and decreased immunolabeling for PAR1, PAR4 and c-MPL were also observed in MKs of two patients. Marked emperipolesis, specific defect of MK alpha-granule content and defect of PAR1-mediated platelet responses are present in all GPS patients that we could study in detail. These results help to further characterize the disease.

1 February 2009 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
LHL. Hernández‐Ruiz
L. Hernández‐Ruiz
ASA. Sáez‐Benito
A. Sáez‐Benito
NPNúria Pujol-Moix
Núria Pujol-Moix
JRJ. Rodríguez‐Martorell
J. Rodríguez‐Martorell
FRFelix A. Ruiz
Felix A. Ruiz

1 September 2018 in Thrombosis Research
Verified
Journal Article
Closed access
MVMiquel Vázquez-Santiago
Miquel Vázquez-Santiago
NVNoelia Vilalta
Noelia Vilalta
BCBiel Cuevas
Biel Cuevas
JMJoaquim Murillo
Joaquim Murillo
DLDolors Llobet
Dolors Llobet
JSJoan Carles Souto
Joan Carles Souto

16 June 2015 in Thrombosis Research
Verified
Journal Article
Closed access
PDF file
NPNúria Pujol-Moix
Núria Pujol-Moix
MVMiquel Vázquez-Santiago
Miquel Vázquez-Santiago
AMAgnès Morera
Agnès Morera
AZAndrey Ziyatdinov
Andrey Ziyatdinov
ARAngel Remacha
Angel Remacha
JSJoan Carles Souto
Joan Carles Souto

Verified
Journal Article
Open access
PDF file
NPNúria Pujol-Moix
Núria Pujol-Moix
Angel Martinez-PerezAngel Martinez-Perez
Angel Martinez-Perez
MSMaria Sabater-Lleal
Maria Sabater-Lleal
DLDolors Llobet
Dolors Llobet
NVNoèlia Vilalta
Noèlia Vilalta
JSJosé Manuel Soria
José Manuel Soria
(1) Background: In a previous study, we found that two phenotypes related to platelet reactivity, measured with the PFA-100 system, were highly heritable. The aim of the present study was to identify genetic determinants that influence the variability of these phenotypes: closure time of collagen-ADP (Col-ADP) and of collagen-epinephrine (Col-Epi). (2) Methods: As part of the GAIT-2 (Genetic Analysis of Idiopathic Thrombophilia (2) Project, 935 individuals from 35 large Spanish families were studied. A genome-wide association study (GWAS) with ≈ 10 M single nucleotide polymorphisms (SNPs) was carried out with Col-ADP and Col-Epi phenotypes. (3) Results: The study yielded significant genetic signals that mapped to the ABO locus. After adjusting both phenotypes for the ABO genotype, these signals disappeared. After adjusting for von Willebrand factor (VWF) or for coagulation factor VIII (FVIII), the significant signals disappeared totally for Col-Epi phenotype but only partially for Col-ADP phenotype. (4) Conclusion: Our results suggest that the ABO locus exerts the main genetic influence on PFA-100 phenotypes. However, while the effect of the ABO locus on Col-Epi phenotype is mediated through VWF and/or FVIII, the effect of the ABO locus on Col-ADP phenotype is partly produced through VWF and/or FVIII, and partly through other mechanisms.

31 March 2023 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
NPNúria Pujol-Moix
Núria Pujol-Moix
EMEduardo Muñiz-Díaz
Eduardo Muñiz-Díaz
IEIgnacio Español
Ignacio Español
SMSergi Mojal
Sergi Mojal
ASAlfons Soler
Alfons Soler
JSJuan Carlos Souto
Juan Carlos Souto